Related Articles |
[Clinical polymorphism of amyotrophic lateral sclerosis].
Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(eight):Four-10
Authors: Kovrazhkina EA, Razinskaya OD, Gubsky LV
Summary
AIM: To make clear scientific polymorphism of amyotrophic lateral sclerosis (ALS).
MATERIAL AND METHODS: The examine was primarily based on data of a hospital personalised register. Ninety-four sufferers, aged from 25 to 81 years, recognized with ALS based on El Escorial standards had been included. Electromyography and, if mandatory, transcranial magnetic stimulation and magnetic-resonance tomography had been used to verify the analysis. Illness development was assessed with the ARSFRS. Age at illness onset, development charge and period of survival of sufferers, uncommon signs of ALS (‘extramotor’), time for palliative care (gastrostomy, non-invasive and invasive lung air flow) and provision of the care to the affected person, household historical past had been recorded in a specifically designed questionnaire.
RESULTS: Many of the sufferers had sporadic ALS, solely two familial instances had been recognized. Spinal onset ALS was present in 66.zero% of the sufferers, bulbar onset in 29.eight%, diffuse onset (spinal and bulbar motor neurons had been affected concurrently) in Four.2%. Average ALS development was noticed in 42.6% of the sufferers, imply time until dying was three.zero±1.2 years. A gradual development was present in sufferers with cervical, low again and bulbar onset. A fast and even ‘momentary’ sort of development was in diffuse and breast onset. An especially gradual development with the long-term hospital remedy and survival >5 years was present in 9.7%. Uncommon ALS signs had been represented by particular cognitive and psychological impairments, a kind of frontal/temporal dysfunction, however solely 5 (5.three%) sufferers had been recognized with ALS-dementia. Indicators of pathological muscle fatigue (myasthenic syndrome) had been recognized in 18 (19.1%), extrapyramidal problems in 5 (5.three%), coordination problems in Four (Four.three%), ache in 12 (12.eight%), sensory signs in 5 (5.three%) of the sufferers.
CONCLUSION: ALS is a multisystemic neurodegeneration illness although the progressive motor neuron dying determines the deadly final result.
PMID: 28884711 [PubMed – indexed for MEDLINE]